Page 3 - Yield10 Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Yield10 bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Yield10 Bioscience Today - Breaking & Trending Today

Yield10 sees 'significant market opportunities' for camelina derived omega-3 fatty acids

Yield10 Bioscience says it has exercised its option to finalize a global, commercial license to advanced omega-3 production technology from UK based Rothamsted Research. ....

United States , Johnathan Napier , Biotechnology Regulatory Services , Professor Johnathan Napier , South America , Regulatory Services , North America , Omega 3 , Yield10 Bioscience ,

Short Interest in Yield10 Bioscience, Inc. (NASDAQ:YTEN) Decreases By 26.6%

Yield10 Bioscience, Inc. (NASDAQ:YTEN – Get Free Report) was the target of a significant drop in short interest in September. As of September 30th, there was short interest totalling 131,300 shares, a drop of 26.6% from the September 15th total of 178,900 shares. Based on an average daily trading volume, of 332,800 shares, the days-to-cover […] ....

United States , Jackw Schuler , Bioscience Company Profile , Wealth Management , Millennium Management , Bioscience Inc , Get Free Report , Street Group , Street Capital , Yield10 Bioscience , Nasdaq Yten , Consumer Staple ,

Yield10 Bioscience, Inc. (NASDAQ:YTEN) Major Shareholder Jack W. Schuler Buys 765,000 Shares

Yield10 Bioscience, Inc. (NASDAQ:YTEN – Get Free Report) major shareholder Jack W. Schuler acquired 765,000 shares of the firm’s stock in a transaction on Tuesday, August 15th. The stock was bought at an average price of $0.65 per share, with a total value of $497,250.00. Following the completion of the acquisition, the insider now directly […] ....

United States , Jackw Schuler , Bioscience Inc , Wealth Management , Securities Exchange Commission , Millennium Management , Get Free Report , Exchange Commission , Street Capital , Street Group , Grand Wealth Management , Yield10 Bioscience , Nasdaq Yten , Consumer Staple , Insider Trading , Nsider Trades ,

Yield10 Bioscience (NASDAQ:YTEN) and YaSheng Group (OTCMKTS:HERB) Critical Analysis

Yield10 Bioscience (NASDAQ:YTEN – Get Free Report) and YaSheng Group (OTCMKTS:HERB – Get Free Report) are both small-cap consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends. Profitability This table compares Yield10 Bioscience […] ....

United States , Bioscience Inc , Yasheng Group , Metabolix Inc , Gansu Yasheng Salt Chemical Industrial Group Ltd , Get Free Report , Given Yield , Sheng Group , Gansu Yasheng Salt Chemical Industrial Group , Yield10 Bioscience , Nasdaq Yten , Consumer Staple , Stock Comparison , Stock Analysis ,

Yield10 Bioscience to Present at the H.C. Wainwright 25th

WOBURN, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience. ....

Bret Shapiro , Lynneh Brum , Eric Fischgrund , Lotte New York Palace Hotel , Bioscience Inc , Oilseeds Inc , Annual Global Investment Conference , Lotte New York Palace , Chief Executive Officer Oliver Peoples , Investor Relations , Nasdaq Yten , Yield10 Bioscience , Hc Wainwright ,